| 英文别名： |
Hyperin;HYPEROSID;HYPEROSIDE;QUERCETIN-3B-D-GALACTOSIDE;QUERCETIN-3-D-GALACTOSIDE;QUERCETIN-3-GALACTOSIDE;QUERCETIN-3-O-GALACTOSIDE;4h-1-benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3-(beta-d-galactopyranosyloxy)-5;hyperasid;hyperozide;2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-;HYPEROSIDE(P);QUERCETIN-3-O-BETA-GALACTOSIDE;HYPEROSIDE WITH HPLC;HYPEROSIDE hplc;3-(β-D-galactopyranosyloxy)-5,7-dihydroxy-;Hyperin, Hyperoside;4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3-(b-D-galactopyranosyloxy)-5,7-dihydroxy-;HYPEROSIDE(AS) PrintBack;HYPEROSIDE(P) PrintBack;Quercetin 3-D-galactoside;Hyperoside,Hyperin,Quercetin 3-D-galactoside;Quercetin 3-galactoside;quercetin 3-O-beta-D-galactopyranoside;3,3′,4′,5,7-Pentahydroxyflavone 3-D-galactoside;Quercetin 3-O-galactoside;[
"Quercetin 3-O-galactoside",
" Hyperoside"
];Jyperin;quercetin galactoside;Quercetin 3-beta-D-galactopyranoside;8O1CR18L82;QUERCETIN 3-B-D-GALACTOSIDE;4H-1-Benzopyra;Hyperoside;SMR000466394;2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one;Isoquercitrin;CCRIS 9339;J6O;CS-0008982;HMS2051H17;3,3',4',5,7-Pentahydroxyflavone 3-D-galactoside;EINECS 207-580-6;ACon1_000623;OVSQVDMCBVZWGM-DTGCRPNFSA-N;Hyperozide;NCGC00168902-03;6-(hydroxymethyl)tetrahydro-2H-pyran-;HYPEROSIDE (CONSTITUENT OF ST. JOHN'S WORT) [DSC];CCG-100970;2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one;Quercetin-3-O-galactoside;Q5242815;2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one;2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-;HY-N0452;HYPEROSIDE [USP-RS];BIDD:PXR0057;2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;Quercetin 3-O-beta-D-galactopyranoside;s5453;3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-;quercetin 3-O-galactoside;Quercetin 3-.beta.-D-galactopyranoside;Hyperin,(S);4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-;2-yloxy)-4H-chromen-4-one;2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one;Hyperoside, United States Pharmacopeia (USP) Reference Standard;CHEBI:67486;MLS000759538;2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one;MEGxp0_000392;482-36-0;QUERCETIN 3-O-.BETA.-D-GALACTOSIDE;NSC-407304;p Hyperin;2-[3,4-bis(oxidanyl)phenyl]-3-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)chromen-4-one;Hyperasid;2-(3,4-dihydroxyphenyl)-5,7-dihyd... |
沪公网安备 
